Registered number
13827380
MKA PHARM LTD
Filleted Accounts
31 January 2024
MKA PHARM LTD
Registered number: 13827380
Balance Sheet
as at 31 January 2024
Notes 2024 2023
£ £
Fixed assets
Tangible assets 3 616 822
Current assets
Cash at bank and in hand 16,312 11,497
Creditors: amounts falling due within one year 4 (2,111) (3,700)
Net current assets 14,201 7,797
Net assets 14,817 8,619
Capital and reserves
Called up share capital 100 100
Profit and loss account 14,717 8,519
Shareholders' funds 14,817 8,619
The directors are satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The members have not required the company to obtain an audit in accordance with section 476 of the Act.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
Saeemha Aslam
Director
Approved by the board on 27 January 2025
MKA PHARM LTD
Notes to the Accounts
for the year ended 31 January 2024
1 Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Tangible fixed assets
Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows:
Plant and machinery over 5 years
Fixtures, fittings, tools and equipment over 5 years
Debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
2 Employees 2024 2023
Number Number
Average number of persons employed by the company 1 1
3 Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 February 2023 1,028
At 31 January 2024 1,028
Depreciation
At 1 February 2023 206
Charge for the year 206
At 31 January 2024 412
Net book value
At 31 January 2024 616
At 31 January 2023 822
4 Creditors: amounts falling due within one year 2024 2023
£ £
Taxation and social security costs 1,737 2,275
Other creditors 374 1,425
2,111 3,700
5 Other information
MKA PHARM LTD is a private company limited by shares and incorporated in England. Its registered office is:
328 Gibbet Street
Halifax
West Yorkshire
United Kingdom
HX1 4JW
MKA PHARM LTD 13827380 false 2023-02-01 2024-01-31 2024-01-31 VT Final Accounts July 2024 Saeemha Aslam No description of principal activity 13827380 2022-02-01 2023-01-31 13827380 core:WithinOneYear 2023-01-31 13827380 core:ShareCapital 2023-01-31 13827380 core:RetainedEarningsAccumulatedLosses 2023-01-31 13827380 2023-02-01 2024-01-31 13827380 bus:PrivateLimitedCompanyLtd 2023-02-01 2024-01-31 13827380 bus:AuditExempt-NoAccountantsReport 2023-02-01 2024-01-31 13827380 bus:Director40 2023-02-01 2024-01-31 13827380 1 2023-02-01 2024-01-31 13827380 2 2023-02-01 2024-01-31 13827380 core:PlantMachinery 2023-02-01 2024-01-31 13827380 countries:England 2023-02-01 2024-01-31 13827380 bus:FRS102 2023-02-01 2024-01-31 13827380 bus:FilletedAccounts 2023-02-01 2024-01-31 13827380 2024-01-31 13827380 core:WithinOneYear 2024-01-31 13827380 core:ShareCapital 2024-01-31 13827380 core:RetainedEarningsAccumulatedLosses 2024-01-31 13827380 core:PlantMachinery 2024-01-31 13827380 2023-01-31 13827380 core:PlantMachinery 2023-01-31 iso4217:GBP xbrli:pure